129 related articles for article (PubMed ID: 9824276)
1. Treatment options in Western hepatocellular carcinoma: a prospective study of 224 patients.
Markovic S; Gadzijev E; Stabuc B; Croce LS; Masutti F; Surlan M; Berden P; Brencic E; Visnar-Perovic A; Sasso F; Ferlan-Marolt V; Mucelli FP; Cesar R; Sponza M; Tiribelli C
J Hepatol; 1998 Oct; 29(4):650-9. PubMed ID: 9824276
[TBL] [Abstract][Full Text] [Related]
2. Transcatheter arterial chemoembolization therapy for patients with hepatocellular carcinoma: a case-controlled study.
Biselli M; Andreone P; Gramenzi A; Trevisani F; Cursaro C; Rossi C; Ricca Rosellini S; Cammà C; Lorenzini S; Stefanini GF; Gasbarrini G; Bernardi M
Clin Gastroenterol Hepatol; 2005 Sep; 3(9):918-25. PubMed ID: 16234031
[TBL] [Abstract][Full Text] [Related]
3. Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: results of a comparative study in 96 Chinese patients.
Yuen MF; Chan AO; Wong BC; Hui CK; Ooi GC; Tso WK; Yuan HJ; Wong DK; Lai CL
Am J Gastroenterol; 2003 May; 98(5):1181-5. PubMed ID: 12809846
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Triple-Drug Transcatheter Arterial Chemoembolization (TACE) With Single-Drug TACE Using Doxorubicin-Eluting Beads: Long-Term Survival in 313 Patients.
Gomes AS; Monteleone PA; Sayre JW; Finn RS; Sadeghi S; Tong MJ; Britten CD; Busuttil RW
AJR Am J Roentgenol; 2017 Oct; 209(4):722-732. PubMed ID: 28705059
[TBL] [Abstract][Full Text] [Related]
5. Survival benefit of patients with inoperable hepatocellular carcinoma treated by a combination of transarterial chemoembolization and percutaneous ethanol injection--a single-center analysis including 132 patients.
Allgaier HP; Deibert P; Olschewski M; Spamer C; Blum U; Gerok W; Blum HE
Int J Cancer; 1998 Dec; 79(6):601-5. PubMed ID: 9842968
[TBL] [Abstract][Full Text] [Related]
6. [Chemoembolization of hepatocellular carcinomas: which factors determine therapeutic response and survival?].
Huppert PE; Lauchart W; Duda SH; Torkler C; Kloska SP; Weinlich M; Benda N; Pereira P; Claussen CD
Rofo; 2004 Mar; 176(3):375-85. PubMed ID: 15026951
[TBL] [Abstract][Full Text] [Related]
7. Overall survival in response to sorafenib with transarterial chemoembolization for BCLC stage B hepatocellular carcinoma: propensity score analysis
.
Huang Y; Chen B; Liu N; Li N; Dao H; Chen W; Yang J
Int J Clin Pharmacol Ther; 2017 Jun; 55(6):498-508. PubMed ID: 28157070
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
Liu C; Sun L; Xu J; Zhao Y
World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic factors and survival according to the Okuda stage in patients with hepatocellular carcinoma].
Kim JH; Han SY; Kang AY; Shon YJ; Koo YH; Ryu SH; Cho JH; Han SH; Lee SW; Jang JS; Lee JH; Roh MH; Choi SR
Korean J Gastroenterol; 2005 Oct; 46(4):283-90. PubMed ID: 16247272
[TBL] [Abstract][Full Text] [Related]
10. Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma.
Cheng JC; Chuang VP; Cheng SH; Huang AT; Lin YM; Cheng TI; Yang PS; You DL; Jian JJ; Tsai SY; Sung JL; Horng CF
Int J Radiat Oncol Biol Phys; 2000 May; 47(2):435-42. PubMed ID: 10802371
[TBL] [Abstract][Full Text] [Related]
11. Survival, efficacy, and safety of small versus large doxorubicin drug-eluting beads TACE chemoembolization in patients with unresectable HCC.
Prajapati HJ; Xing M; Spivey JR; Hanish SI; El-Rayes BF; Kauh JS; Chen Z; Kim HS
AJR Am J Roentgenol; 2014 Dec; 203(6):W706-14. PubMed ID: 25415737
[TBL] [Abstract][Full Text] [Related]
12. Three-dimensional conformal radiation therapy for unresectable hepatocellular carcinoma patients who had failed with or were unsuited for transcatheter arterial chemoembolization.
Liu MT; Li SH; Chu TC; Hsieh CY; Wang AY; Chang TH; Pi CP; Huang CC; Lin JP
Jpn J Clin Oncol; 2004 Sep; 34(9):532-9. PubMed ID: 15466827
[TBL] [Abstract][Full Text] [Related]
13. Value of the model for end-stage liver disease for predicting survival in hepatocellular carcinoma patients treated with transarterial chemoembolization.
Kim JH; Kim JH; Choi JH; Kim CH; Jung YK; Yim HJ; Yeon JE; Park JJ; Kim JS; Bak YT; Byun KS
Scand J Gastroenterol; 2009; 44(3):346-57. PubMed ID: 18991165
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effects and prognostic factors in three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma.
Wu DH; Liu L; Chen LH
World J Gastroenterol; 2004 Aug; 10(15):2184-9. PubMed ID: 15259062
[TBL] [Abstract][Full Text] [Related]
15. Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma.
Song MJ; Bae SH; Lee JS; Lee SW; Song DS; You CR; Choi JY; Yoon SK
Korean J Intern Med; 2016 Mar; 31(2):242-52. PubMed ID: 26874512
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic efficacy of transcatheter arterial chemoembolization as compared with hepatic resection in hepatocellular carcinoma patients with compensated liver function in a hepatitis B virus-endemic area: a prospective cohort study.
Lee HS; Kim KM; Yoon JH; Lee TR; Suh KS; Lee KU; Chung JW; Park JH; Kim CY
J Clin Oncol; 2002 Nov; 20(22):4459-65. PubMed ID: 12431969
[TBL] [Abstract][Full Text] [Related]
17. Prognostic accuracy of 12 liver staging systems in patients with unresectable hepatocellular carcinoma treated with transarterial chemoembolization.
Georgiades CS; Liapi E; Frangakis C; Park JU; Kim HW; Hong K; Geschwind JF
J Vasc Interv Radiol; 2006 Oct; 17(10):1619-24. PubMed ID: 17057003
[TBL] [Abstract][Full Text] [Related]
18. Treatment choice for early-stage hepatocellular carcinoma in real-world practice: impact of treatment stage migration to transarterial chemoembolization and treatment response on survival.
Roberts SK; Gazzola A; Lubel J; Gow P; Bell S; Nicoll A; Dev A; Fink MA; Sood S; Knight V; Hong T; Paul E; Mishra G; Majeed A; Kemp W;
Scand J Gastroenterol; 2018; 53(10-11):1368-1375. PubMed ID: 30394145
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery.
Huang YH; Chen CH; Chang TT; Chen SC; Wang SY; Lee HS; Lin PW; Huang GT; Sheu JC; Tsai HM; Lee PC; Chau GY; Lui WY; Lee SD; Wu JC
J Gastroenterol Hepatol; 2005 May; 20(5):765-71. PubMed ID: 15853992
[TBL] [Abstract][Full Text] [Related]
20. The ART score is not effective to select patients for transarterial chemoembolization retreatment in an Italian series.
Terzi E; Terenzi L; Venerandi L; Croci L; Renzulli M; Mosconi C; Allegretti G; Granito A; Golfieri R; Bolondi L; Piscaglia F
Dig Dis; 2014; 32(6):711-6. PubMed ID: 25376288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]